Guidelines for tyrosine kinase inhibitor (TKI)-treated chronic phase-chronic myeloid
leukemia (CML) management are essentially based on data from clinical research trials; …

Purpose Red blood cell distribution width (RDW) has been considered as a potential
indicator of the effects of treatment or as a prognostic indicator for various malignancies …

Simple Summary This review explores the use of hematopoietic stem cell transplantation
(HSCT) as a treatment option for chronic myeloid leukemia (CML) patients. While CML …

Objective: To study the pharmacological mechanism of procyanidin B2 (PCB2) on chronic
myeloid leukemia (CML) by integrating network pharmacological methods systematically …

The CD99 gene encodes a transmembrane protein that is involved in cell differentiation,
adhesion, migration, and protein trafficking. CD99 is differentially expressed on the surface …

Chronic myelogenous leukemia (CML) is characterized by Philadelphia translocation arising
from Bcr-Abl fusion gene, which encodes abnormal oncoprotein showing tyrosine kinase …

The studies concerned the expression of sulfurtransferases and cystathionine beta-synthase
in six human leukemia cell lines: B cell acute lymphoblastic leukemia-B-ALL (REH cells), T …

Leukemia is a group of malignant disorders which affect the blood and blood-forming tissues
in the bone marrow, lymphatic system, and spleen. Many types of leukemia exist; thus, their …

Cancer remains the second leading cause of mortality globally. In combating cancer,
conventional chemotherapy and/or radiotherapy are administered as first-line therapy …

The introduction of various targeted agents into the armamentarium of cancer treatment has
revolutionized the standard care of patients with cancer. However, like conventional …